Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 5/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.40 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.40 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31571685 | 1.00 | CHRM2 (0.40) | CHRM2CHRM1CHRM4CHRM3CYP2D6 | |
| SCHEMBL1691359 | 0.85 | EPHX1 (0.31) | EPHX1 | |
| SCHEMBL6274585 | 0.85 | EPHX1 (0.31) | EPHX1 | |
| SCHEMBL14256116 | 0.85 | EPHX1 (0.31) | EPHX1 | |
| SCHEMBL1536315 | 0.85 | EPHX1 (0.31) | EPHX1 | |
| SCHEMBL29962370 | 0.84 | — | — | |
| SCHEMBL10233880 | 0.83 | TSHR (0.33) | TSHR | |
| SCHEMBL8713296 | 0.82 | EPHX1 (0.30) | EPHX1 | |
| SCHEMBL10233840 | 0.80 | TSHR (0.33) | TSHR | |
| SCHEMBL19066069 | 0.80 | TSHR (0.33) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104837973-B | Fragrance materials | 宝洁公司 | 2020-04-21 | — | — | CN | claimed |
| CN-116018124-A | Composition for limiting or eliminating sweat odor perception | 弗门尼舍有限公司 | 2023-04-25 | — | — | CN | disclosed |
| CN-115992113-A | P-nitrobenzyl esterase mutant, coding gene and application | 浙江工业大学 | 2023-04-21 | — | — | CN | disclosed |
| CN-111433337-A | Perfume composition | 狮王株式会社 | 2020-07-17 | — | — | CN | disclosed |
| US-20040209858-A1 | Cycloalkylamides and their therapeutic applications | ABBOTT LABORATORIES | 2004-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040209858-A1 | Cycloalkylamides and their therapeutic applications | GAP43, SCN1B, GRIN2B | CHRM2 1034/4885CHRM1 887/4885CHRM4 1220/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.